SCHEMBL9004683

SCHEMBL9004683

COc1ccccc1NC(=O)NN=c1c(=O)c2ccccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP6 Q9GZR1 3/20 0.56
ALDH1A1 P00352 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
MAPT P10636 5/20 0.51
CASP3 P42574 2/20 0.51
SENP8 Q96LD8 2/20 0.51
SENP7 Q9BQF6 2/20 0.51
KMT2A Q03164 2/20 0.51
APAF1 O14727 1/20 0.51
TDP2 O95551 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
POLB P06746 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004634 0.87 SENP6 (0.49) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004762 0.86 MEN1 (0.60) SENP6ALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL9004650 0.82 MAPT (0.51) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004785 0.81 KMT2A (0.52) SENP6ALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL9004741 0.80 MAPT (0.53) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004684 0.80 SENP6 (0.62) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004654 0.79 KMT2A (0.51) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004668 0.79 RAB9A (0.57) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9232385 0.79 SENP6 (0.51) SENP6ALDH1A1SMN1; SMN2MAPTCASP3
SCHEMBL9004618 0.79 KMT2A (0.63) SENP6ALDH1A1SMN1; SMN2MAPTCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed